NCT06090539 A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas Status RECRUITING Phase PHASE1/PHASE2
NCT06088264 A Study to Evaluate the Drug Levels, Metabolism, and Removal of BMS-986322 in Healthy Adult Male Participants Status COMPLETED Phase PHASE1
NCT06086886 A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants Status COMPLETED Phase PHASE1
NCT06084598 A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity Status COMPLETED Phase PHASE1
NCT06073873 A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea Status RECRUITING Phase N/A
NCT06073860 A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia Status RECRUITING Phase N/A
NCT06073847 A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis Status RECRUITING Phase N/A
NCT06073769 A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia Status RECRUITING Phase N/A
NCT06067841 A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer Status RECRUITING Phase PHASE1
NCT06050512 Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE1/PHASE2
NCT06045806 A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06045689 A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06042920 A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis Status TERMINATED Phase PHASE4
NCT06035497 A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06034899 A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants Status WITHDRAWN Phase PHASE1
NCT06027437 A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06025578 A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06024174 A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT06023186 Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM Status RECRUITING Phase N/A
NCT06015724 Anti-CD38 Antibody With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2